These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4723354)

  • 41. [Clinical significance of haptoglobin in chronic hepatitis and liver cirrhosis of viral etiology].
    Denisenko LN
    Ter Arkh; 1971 Oct; 43(10):38-41. PubMed ID: 5140948
    [No Abstract]   [Full Text] [Related]  

  • 42. M-components in patients with chronic liver disease.
    Ellman LL; Pachas WN; Pinals RS; Bloch KJ
    Gastroenterology; 1969 Aug; 57(2):138-42. PubMed ID: 5799671
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparative evaluation of biochemical tests to determine the activity of the pathological process in patients with chronic hepatitis and cirrhosis of the liver who are receiving glucocorticoid therapy].
    Shul'man VSh; Tatarinova OM; Barenblat GZ
    Ter Arkh; 1969 Nov; 41(11):88-93. PubMed ID: 5384756
    [No Abstract]   [Full Text] [Related]  

  • 44. [Influence of Fuzheng Huayu Capsules on abnormal amino acids spectrum in chronic liver diseases].
    Huang YK; Zhao CQ; Hu YY; Xue HM; Liu C; Liu P
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):230-1. PubMed ID: 15760567
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study of plasma lipids in patients with liver cirrhosis and hepatitis].
    Platzer S; Sailer S; Sandhofer F; Braunsteiner H
    Wien Klin Wochenschr; 1966 Jan; 78(4):56-8. PubMed ID: 5962258
    [No Abstract]   [Full Text] [Related]  

  • 46. [Anemic syndrome in chronic hepatitis and liver cirrhosis].
    Korolko IuR; Sarycheva TG; Kotelńikov VM; Kozinets GI; Zherebtsov LA
    Klin Med (Mosk); 1993; 71(5):45-8. PubMed ID: 8301986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

  • 48. Variations of serum glucose, insulin and neutral amino-acids during prolonged glucose infusion in liver cirrhosis.
    Rocchi E; Gibertini P; Zeneroli ML; Farina F; Grandi R; Cassanelli M; Ventura E
    Med Chir Dig; 1980; 9(6):489-95. PubMed ID: 7010016
    [No Abstract]   [Full Text] [Related]  

  • 49. [Changes of carbohydrate components of blood glycoproteids in chronic hepatitis].
    Fehér J; Jakab L; Józsa L; Papp G
    Z Gesamte Inn Med; 1972 Aug; 27(15):658-62. PubMed ID: 4641140
    [No Abstract]   [Full Text] [Related]  

  • 50. [Value of zonal blood protein electrophoresis in polyacrylamide gel in various digestive system diseases].
    Samson EI; Gotsuliak OF
    Lab Delo; 1980; (4):214-6. PubMed ID: 6155544
    [No Abstract]   [Full Text] [Related]  

  • 51. [Serum protein changes in chronic inflammatory liver diseases].
    Giurov L; Ivanov B; Dochev D
    Vutr Boles; 1986; 25(5):78-81. PubMed ID: 3811340
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fatty acid composition of the blood plasma lipids in chronic hepatitis and liver cirrhosis in children].
    Pashkevich DD; Fatkhullin IA; Markov KhM
    Pediatriia; 1983 Jan; (1):36-8. PubMed ID: 6835793
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiocopper (64Cu) incorporation into ceruloplasmin in chronic active hepatitis and in liver cirrhosis.
    Piaggi V; Zeneroli ML; Rocchi E; Gibertini P; Cremonini C; Gozzi MG; Ventura E
    J Nucl Med Allied Sci; 1980; 24(3-4):177-81. PubMed ID: 7252581
    [No Abstract]   [Full Text] [Related]  

  • 55. Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.
    Makino I; Nakagawa S; Mashimo K
    Gastroenterology; 1969 Jun; 56(6):1033-9. PubMed ID: 5788911
    [No Abstract]   [Full Text] [Related]  

  • 56. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R; Knief J; Faul J
    Med Klin; 1968 Sep; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasma free amino acid pattern in chronic hepatitis as a sensitive and prognostic index.
    Kano T; Nagaki M; Takahashi T; Ohnishi H; Saitoh K; Kimura K; Muto Y
    Gastroenterol Jpn; 1991 Jun; 26(3):344-9. PubMed ID: 1889691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bile acids in the serum of patients with extrahepatic cholestasis with chronic liver diseases].
    Erb W; Schreiber J; Walczak M
    Z Gastroenterol; 1973 May; 11(4):279-88. PubMed ID: 4803425
    [No Abstract]   [Full Text] [Related]  

  • 59. [Glycolipidemic variations during the double glucagon test in patients with liver diseases].
    Sgambato S; Carbone L; Torella R; Frascolla N; Drammis E
    G Clin Med; 1977; 58(7-8):301-11. PubMed ID: 924051
    [No Abstract]   [Full Text] [Related]  

  • 60. [On lipoprotein lipase activity, serum lipids and the effect of heparin on the blood sugar level in atrophic liver cirrhosis and chronic hepatitis].
    Bosadjiewa E; Warbanow G; Markowski S; Beltschew L; Russinow E
    Z Gesamte Inn Med; 1967 Jul; 22(13):393-6. PubMed ID: 5595619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.